Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...

In 2008, Madeline “Kara” Neumann, age 11, died of diabetic ketoacidosis in Wisconsin. Her parents treated her symptoms with ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...